Practice Advantage
Live From Vision Expo West: Newton and the Sequel Ophthalmic Lens Portfolio with Davis Corley
Episode Summary
Neurolens has rebranded to Newton, bringing with it a new lens portfolio and a new direction. CEO Davis Corley shares more on the new direction for the company.
Episode Notes
We're live from Vision Expo West in Las Vegas in the buzz of the show, discussing the new direction for Newton, formerly Neurolens with CEO and co-founder Davis Corley.
Key Takeaways:
- Newton was inspired by Isaac Newton, one of the earliest fathers of optics and prism opening a new direction for three pillars: Sequel, Neurolens, and AI innovation.
- Sequel is the newest lens portfolio to hit the market, spanning two near relaxing designs and a full progressive. Driven by Convergence Boost technology, the lens eliminates the varients in prismatic effect as patients move form distance to near.
- Neurolens continues as the flagship product for Newton, leveraging the N3 device to deliver therapeutic optics to patients with symptomatic convergence issues.
- Newton is also investing in Isaac, an AI innovation and training platform to support private practice staff training and development.
What Davis is reading:
Practice Advantage Reading List
** Don't miss out on an extra $15 rebate for all commercial VSP Eye Exams this year - with $15 extended through June of 2026, and $10 thru the end of next year! Visit www.pecaaexamrebate.com now!**